Gibson, Dunn & Crutcher LLP has advised Gyre Therapeutics, and Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. has advised Cullgen Inc. Gyre Therapeutics, Inc., an…
Gyre Therapeutics Acquires Cullgen in $300 Million All-Stock Transaction


Gibson, Dunn & Crutcher LLP has advised Gyre Therapeutics, and Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. has advised Cullgen Inc. Gyre Therapeutics, Inc., an…
…